نتائج البحث

Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand‐1 (PD‐L1) expression in surgically resected non‐small cell lung cancer.

• Authors : Shigeta, Naoko¹ (AUTHOR); Murakami, Shuji² (AUTHOR) ; Yokose, Tomoyuki³ (AUTHOR)

• Source: Thoracic Cancer. Jun2024, Vol. 15 Issue 17, p1343-1349. 7p.

تفاصيل العنوان

Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte, Programmed Death Ligand-1 Expression with Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer.

• Authors : Lee J; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.

Subjects: Gene Expression* ; Tumor Microenvironment*; B7-H1 Antigen/B7-H1 Antigen/B7-H1 Antigen/*genetics

• Source: Cancer research and treatment [Cancer Res Treat] 2019 Apr; Vol. 51 (2), pp. 649-663. Date of Electronic Publication: 2018 Jul 31.Publisher: The Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Programmed death ligand-1 testing in adenocarcinoma lung: A comparative study of cell block versus biopsy.

• Authors : Shukla, Saumya¹; Pandey, Rahul¹; Gupta, Vani¹

• Source: Journal of Cytology. Oct-Dec2023, Vol. 40 Issue 4, p165-168. 4p.

تفاصيل العنوان

Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes.

• Authors : Kobayashi, Nobuaki¹ (AUTHOR) ; Miura, Kenji² (AUTHOR) ; Kaneko, Ayami¹ (AUTHOR)

• Source: Cancers. Nov2023, Vol. 15 Issue 21, p5248. 16p.

تفاصيل العنوان

Prognostic Value of Programmed Death Ligand-1 in Discriminating Patients With Lymph Node--Negative, p53--Wild-Type, or Low-BRCA1/2-Expression Pancreatic Ductal Adenocarcinoma.

• Authors : Xianlong Chen¹; Yue Zhang¹; Shengwei Mo¹

• Source: Archives of Pathology & Laboratory Medicine. Apr2023, Vol. 147 Issue 4, p465-473. 9p. 2 Color Photographs, 4 Charts, 2 Graphs.

تفاصيل العنوان

Programmed Death Ligand-1 Expression Is Associated With Poorer Survival in Anal Squamous Cell Carcinoma.

• Authors : Monsrud, Ashley L.¹; Avadhani, Vaidehi¹; Mosunjac, Marina B.¹

• Source: Archives of Pathology & Laboratory Medicine. Sep2022, Vol. 146 Issue 9, p1094-1101. 8p. 1 Color Photograph, 5 Charts, 2 Graphs.

تفاصيل العنوان

Programmed death ligand-1 expression is associated with stage and histological grade of parotid carcinoma.

• Authors : Masaaki Higashino¹; Ryo Kawata¹ ; Shuji Nishikawa¹

• Source: Acta Oto-Laryngologica (Supplement). 2020, Vol. 140 Issue 2, p175-180. 6p.

تفاصيل العنوان

Programmed death ligand-1 expression is associated with stage and histological grade of parotid carcinoma.

• Authors : Higashino, Masaaki¹ (AUTHOR); Kawata, Ryo¹ (AUTHOR) ; Nishikawa, Shuji¹ (AUTHOR)

• Source: Acta Oto-Laryngologica. Feb2020, Vol. 140 Issue 2, p175-180. 6p.

تفاصيل العنوان

Analytical Validation and Clinical Utility of an Immunohistochemical Programmed Death Ligand-1 Diagnostic Assay and Combined Tumor and Immune Cell Scoring Algorithm for Durvalumab in Urothelial Carcinoma.

• Authors : Zajac, Magdalena¹ ; Boothman, Anne-Marie¹; Ben, Yong^2,3

• Source: Archives of Pathology & Laboratory Medicine. Jun2019, Vol. 143 Issue 6, p722-731. 10p. 2 Diagrams, 7 Charts.

تفاصيل العنوان

Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer.

• Authors : Kulangara, Karina¹; Zhang, Nancy¹; Corigliano, Ellie^1,2

• Source: Archives of Pathology & Laboratory Medicine. Mar2019, Vol. 143 Issue 3, p330-337. 8p. 1 Color Photograph, 4 Charts, 1 Graph.

تفاصيل العنوان